BG64649B1 - Нови дихидропиримидини - Google Patents
Нови дихидропиримидини Download PDFInfo
- Publication number
- BG64649B1 BG64649B1 BG104812A BG10481200A BG64649B1 BG 64649 B1 BG64649 B1 BG 64649B1 BG 104812 A BG104812 A BG 104812A BG 10481200 A BG10481200 A BG 10481200A BG 64649 B1 BG64649 B1 BG 64649B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- substituted
- phenyl
- optionally substituted
- compounds
- Prior art date
Links
- AONWNQKBYSNDDD-DMKPSLHHSA-N CC1=C(C2OC2OC)[C@H](c(ccc(F)c2)c2Cl)N=C(c2ncccc2Cl)N1 Chemical compound CC1=C(C2OC2OC)[C@H](c(ccc(F)c2)c2Cl)N=C(c2ncccc2Cl)N1 AONWNQKBYSNDDD-DMKPSLHHSA-N 0.000 description 1
- BWOUDKGHEQTUNE-UHFFFAOYSA-N CCOC(C1=C(C)NC(c(ncc(F)c2)c2F)=NC1c(c(F)c1)ccc1Br)=O Chemical compound CCOC(C1=C(C)NC(c(ncc(F)c2)c2F)=NC1c(c(F)c1)ccc1Br)=O BWOUDKGHEQTUNE-UHFFFAOYSA-N 0.000 description 1
- QAQDKCIGHLJWCU-UHFFFAOYSA-N CCOC1OC1C(C(c(c(F)c1)ccc1Cl)N=C(c(c(F)c1)ncc1F)N1)=C1[IH2] Chemical compound CCOC1OC1C(C(c(c(F)c1)ccc1Cl)N=C(c(c(F)c1)ncc1F)N1)=C1[IH2] QAQDKCIGHLJWCU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19817264A DE19817264A1 (de) | 1998-04-18 | 1998-04-18 | Neue Dihydropyrimidine |
Publications (2)
Publication Number | Publication Date |
---|---|
BG104812A BG104812A (en) | 2001-06-29 |
BG64649B1 true BG64649B1 (bg) | 2005-10-31 |
Family
ID=7864972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104812A BG64649B1 (bg) | 1998-04-18 | 2000-09-29 | Нови дихидропиримидини |
Country Status (37)
Country | Link |
---|---|
US (3) | US6696451B1 (fr) |
EP (1) | EP1080086B1 (fr) |
JP (2) | JP4590097B2 (fr) |
KR (1) | KR100636771B1 (fr) |
CN (1) | CN1159311C (fr) |
AR (1) | AR018187A1 (fr) |
AT (1) | ATE223401T1 (fr) |
AU (1) | AU740318B2 (fr) |
BG (1) | BG64649B1 (fr) |
BR (2) | BR9909730B1 (fr) |
CA (1) | CA2328780C (fr) |
CO (1) | CO5021127A1 (fr) |
CU (1) | CU23049A3 (fr) |
CZ (1) | CZ293482B6 (fr) |
DE (2) | DE19817264A1 (fr) |
DK (1) | DK1080086T3 (fr) |
ES (1) | ES2183548T3 (fr) |
GT (1) | GT199900056A (fr) |
HK (1) | HK1039119A1 (fr) |
HU (1) | HUP0102372A3 (fr) |
ID (1) | ID27263A (fr) |
IL (2) | IL138584A0 (fr) |
MY (1) | MY126527A (fr) |
NO (2) | NO321985B1 (fr) |
NZ (1) | NZ507569A (fr) |
PE (1) | PE20000427A1 (fr) |
PL (1) | PL193898B1 (fr) |
PT (1) | PT1080086E (fr) |
RU (1) | RU2245881C9 (fr) |
SI (1) | SI1080086T1 (fr) |
SK (1) | SK286407B6 (fr) |
SV (1) | SV1999000047A (fr) |
TR (1) | TR200003011T2 (fr) |
TW (1) | TW548274B (fr) |
UA (1) | UA63998C2 (fr) |
WO (1) | WO1999054326A1 (fr) |
ZA (1) | ZA200005136B (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4289100A (en) * | 1999-03-25 | 2000-10-16 | Bayer Aktiengesellschaft | Dihydropyrimidines and their use in the treatment of hepatitis |
AU5568400A (en) | 1999-06-23 | 2001-01-09 | Ajinomoto Co., Inc. | Novel dihydropyrimidine derivatives |
WO2001045712A1 (fr) * | 1999-12-22 | 2001-06-28 | Bayer Aktiengesellschaft | Combinaison de medicaments pour lutter contre des maladies virales |
DE10012823A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
DE10013125A1 (de) * | 2000-03-17 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
DE10013126A1 (de) * | 2000-03-17 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
DE10125131A1 (de) * | 2001-05-23 | 2002-12-05 | Bayer Ag | Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats |
US20040092735A1 (en) * | 2002-11-08 | 2004-05-13 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of cefuroxime sodium |
CN101104617B (zh) * | 2006-07-10 | 2010-06-23 | 北京摩力克科技有限公司 | 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途 |
CN101104604B (zh) | 2006-07-10 | 2011-03-02 | 北京摩力克科技有限公司 | 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途 |
RU2452733C2 (ru) * | 2007-04-27 | 2012-06-10 | Пэдью Фарма Л.П. | Антагонисты trpv1 и их применение |
PT2514750E (pt) * | 2007-06-18 | 2014-01-23 | Sunshine Lake Pharma Co Ltd | Tiazolil dihidropirimidinas substituídas com bromo-fenilo |
BRPI0815562A2 (pt) | 2007-07-12 | 2015-02-18 | Novartis Ag | Soluções farmacêuticas orais contendo telbivudina. |
US20130267517A1 (en) | 2012-03-31 | 2013-10-10 | Hoffmann-La Roche Inc. | Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
AU2013305390C1 (en) | 2012-08-24 | 2015-12-24 | Ruyuan Wei Xiang Technology Co., Ltd. | Dihydropyrimidine compounds and their application in pharmaceuticals |
SG11201500377UA (en) | 2012-09-10 | 2015-02-27 | Hoffmann La Roche | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
CN103664899B (zh) * | 2012-09-11 | 2017-06-16 | 广东东阳光药业有限公司 | 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用 |
US20150292045A1 (en) * | 2012-11-09 | 2015-10-15 | Indiana University Research And Technology Corporation | Alternative uses for hbv assembly effectors |
CN110960778B (zh) | 2013-03-15 | 2022-09-30 | 费雪派克医疗保健有限公司 | 用于医疗回路的组件 |
BR102014028162A2 (pt) * | 2013-11-12 | 2015-09-08 | Dow Agrosciences Llc | processo para fluoração de compostos |
CA2920415A1 (fr) | 2013-11-19 | 2015-05-28 | Sunshine Lake Pharma Co., Ltd. | Composes dihydropyrimidine et leur application dans des produits pharmaceutiques |
AU2014356984B2 (en) | 2013-11-27 | 2018-01-04 | Sunshine Lake Pharma Co., Ltd. | Processes for preparing dihydropyrimidine derivatives and intermediates thereof |
US9771358B2 (en) | 2014-03-28 | 2017-09-26 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and their application in pharmaceuticals |
CN105153164B (zh) * | 2014-05-30 | 2018-10-30 | 齐鲁制药有限公司 | 作为hbv抑制剂的二氢嘧啶并环衍生物 |
EP3150600B1 (fr) * | 2014-05-30 | 2018-06-27 | Qilu Pharmaceutical Co., Ltd. | Dérivé de boucle dihydropyrimido à titre d'inhibiteur du vhb |
AU2016214799A1 (en) | 2015-02-07 | 2017-06-15 | Sunshine Lake Pharma Co., Ltd. | Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals |
WO2019001420A1 (fr) * | 2017-06-27 | 2019-01-03 | Janssen Pharmaceutica Nv | Dérivés hétéroaryldihydropyrimidine et méthodes de traitement d'infections par le virus de l'hépatite b |
US10759774B2 (en) | 2017-09-28 | 2020-09-01 | The Curators Of The University Of Missouri | Inhibitors of hepatitis B virus targeting capsid assembly |
WO2019086141A1 (fr) | 2017-11-02 | 2019-05-09 | Aicuris Gmbh & Co. Kg | Nouveaux indole-2-carboxamides à substitution amino-thiazole hautement actifs agissant contre le virus de l'hépatite b (vhb) |
BR112020008765A2 (pt) | 2017-11-02 | 2020-10-20 | Aicuris Gmbh & Co. Kg | indol-2-carboxamidas pirazolo-piperidina substituídas altamente ativas inovadoras ativas contra o vírus da hepatite b (hbv) |
US20210220356A1 (en) * | 2018-05-08 | 2021-07-22 | Janssen Sciences Ireland Unlimited Company | Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases |
US11053235B2 (en) | 2018-08-09 | 2021-07-06 | Janssen Sciences Ireland Unlimited Company | Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases |
AR116946A1 (es) | 2018-11-02 | 2021-06-30 | Aicuris Gmbh & Co Kg | Derivados de urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb) |
SG11202104132WA (en) * | 2018-11-02 | 2021-05-28 | Aicuris Gmbh & Co Kg | Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv) |
UY38434A (es) | 2018-11-02 | 2020-05-29 | Aicuris Gmbh & Co Kg | Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv) |
AR116947A1 (es) | 2018-11-02 | 2021-06-30 | Aicuris Gmbh & Co Kg | Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb) |
UY38435A (es) | 2018-11-02 | 2020-05-29 | Aicuris Gmbh & Co Kg | Nuevas urea 6,7-dihidro-4h-pirazol[1,5-a] pirazinas activas contra el virus de la hepatitis b (vhb) |
UY38437A (es) | 2018-11-02 | 2020-05-29 | Aicuris Gmbh & Co Kg | Nuevas urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (hbv) |
US20220048919A1 (en) | 2018-12-20 | 2022-02-17 | Janssen Phrmaceutica NV | Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections |
SG11202111198QA (en) | 2019-04-30 | 2021-11-29 | Aicuris Gmbh & Co Kg | Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv) |
WO2020221826A1 (fr) | 2019-04-30 | 2020-11-05 | Aicuris Gmbh & Co. Kg | Nouveaux indole-2-carboxamides actifs contre le virus de l'hépatite b (vhb) |
EP3962909B1 (fr) | 2019-04-30 | 2023-10-04 | AiCuris GmbH & Co. KG | Nouvelles pipérazines d'oxalyle actives contre le virus de l'hépatite b (vhb) |
JP2022531199A (ja) | 2019-04-30 | 2022-07-06 | アイクリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | B型肝炎ウイルス(hbv)に対し活性な新規のフェニル及びピリジル尿素 |
WO2020255016A1 (fr) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combinaison de vaccins contre le virus de l'hépatite b (vhb) et de dérivés de dihydropyrimidine en tant que modulateurs de l'assemblage des capsides |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0103796A2 (fr) * | 1982-09-18 | 1984-03-28 | Bayer Ag | Dihydropyrimidines, leur procédé de préparation et leur emploi dans des médicaments |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH550189A (de) | 1971-01-08 | 1974-06-14 | Ciba Geigy Ag | Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren. |
CH569043A5 (fr) | 1973-01-23 | 1975-11-14 | Ciba Geigy Ag | |
US4371537A (en) * | 1981-08-13 | 1983-02-01 | The Dow Chemical Company | Sulfur-substituted phenoxypyridines having antiviral activity |
JPS60185764A (ja) * | 1984-03-05 | 1985-09-21 | Wako Pure Chem Ind Ltd | ピリジン誘導体の新規な製造法 |
US4698340A (en) | 1984-07-19 | 1987-10-06 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine derivatives, processes for preparation thereof and composition containing the same |
US4727073A (en) | 1984-10-01 | 1988-02-23 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine derivatives and composition of the same |
GB8906168D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
EP0941222A2 (fr) * | 1996-11-12 | 1999-09-15 | Novartis AG | Derives pyrazole utiles comme herbicides |
SE9702564D0 (sv) * | 1997-07-02 | 1997-07-02 | Astra Ab | New compounds |
-
1998
- 1998-04-18 DE DE19817264A patent/DE19817264A1/de not_active Withdrawn
-
1999
- 1999-04-07 PT PT99920603T patent/PT1080086E/pt unknown
- 1999-04-07 ID IDW20002111A patent/ID27263A/id unknown
- 1999-04-07 AT AT99920603T patent/ATE223401T1/de active
- 1999-04-07 DK DK99920603T patent/DK1080086T3/da active
- 1999-04-07 DE DE59902573T patent/DE59902573D1/de not_active Expired - Lifetime
- 1999-04-07 CU CU20000220A patent/CU23049A3/es unknown
- 1999-04-07 US US09/673,592 patent/US6696451B1/en not_active Expired - Lifetime
- 1999-04-07 AU AU38133/99A patent/AU740318B2/en not_active Expired
- 1999-04-07 CN CNB998074950A patent/CN1159311C/zh not_active Expired - Lifetime
- 1999-04-07 NZ NZ507569A patent/NZ507569A/en not_active IP Right Cessation
- 1999-04-07 BR BRPI9909730-3A patent/BR9909730B1/pt not_active IP Right Cessation
- 1999-04-07 JP JP2000544665A patent/JP4590097B2/ja not_active Expired - Lifetime
- 1999-04-07 SI SI9930139T patent/SI1080086T1/xx unknown
- 1999-04-07 ES ES99920603T patent/ES2183548T3/es not_active Expired - Lifetime
- 1999-04-07 KR KR1020007011527A patent/KR100636771B1/ko not_active IP Right Cessation
- 1999-04-07 CA CA002328780A patent/CA2328780C/fr not_active Expired - Lifetime
- 1999-04-07 TR TR2000/03011T patent/TR200003011T2/xx unknown
- 1999-04-07 EP EP99920603A patent/EP1080086B1/fr not_active Expired - Lifetime
- 1999-04-07 SK SK1565-2000A patent/SK286407B6/sk not_active IP Right Cessation
- 1999-04-07 BR BRPI9917862A patent/BRPI9917862B8/pt not_active IP Right Cessation
- 1999-04-07 WO PCT/EP1999/002344 patent/WO1999054326A1/fr active IP Right Grant
- 1999-04-07 PL PL99343481A patent/PL193898B1/pl unknown
- 1999-04-07 IL IL13858499A patent/IL138584A0/xx active IP Right Grant
- 1999-04-07 RU RU2000129148/04A patent/RU2245881C9/ru active
- 1999-04-07 HU HU0102372A patent/HUP0102372A3/hu unknown
- 1999-04-07 CZ CZ20003871A patent/CZ293482B6/cs not_active IP Right Cessation
- 1999-04-15 PE PE1999000309A patent/PE20000427A1/es not_active IP Right Cessation
- 1999-04-16 AR ARP990101779A patent/AR018187A1/es active IP Right Grant
- 1999-04-16 MY MYPI99001481A patent/MY126527A/en unknown
- 1999-04-16 SV SV1999000047A patent/SV1999000047A/es active IP Right Grant
- 1999-04-16 CO CO99022937A patent/CO5021127A1/es unknown
- 1999-04-16 GT GT199900056A patent/GT199900056A/es unknown
- 1999-04-16 TW TW088106067A patent/TW548274B/zh active
- 1999-07-04 UA UA2000116511A patent/UA63998C2/uk unknown
-
2000
- 2000-09-20 IL IL138584A patent/IL138584A/en not_active IP Right Cessation
- 2000-09-26 ZA ZA200005136A patent/ZA200005136B/xx unknown
- 2000-09-29 BG BG104812A patent/BG64649B1/bg unknown
- 2000-10-17 NO NO20005215A patent/NO321985B1/no not_active IP Right Cessation
-
2002
- 2002-01-21 HK HK02100473A patent/HK1039119A1/xx not_active IP Right Cessation
-
2004
- 2004-02-17 US US10/781,075 patent/US20040167135A1/en not_active Abandoned
- 2004-12-01 NO NO20045259A patent/NO329020B1/no not_active IP Right Cessation
-
2006
- 2006-12-15 US US11/639,955 patent/US7514565B2/en not_active Expired - Fee Related
-
2010
- 2010-07-23 JP JP2010165860A patent/JP5237332B2/ja not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0103796A2 (fr) * | 1982-09-18 | 1984-03-28 | Bayer Ag | Dihydropyrimidines, leur procédé de préparation et leur emploi dans des médicaments |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG64649B1 (bg) | Нови дихидропиримидини | |
US6417202B1 (en) | Pyridylpyrrole compounds useful as interleukin-and TNF antagonists | |
US6436943B1 (en) | Use of dihydropyrimidines as medicaments, and novel substances | |
BG65106B1 (bg) | Заместени 2-арил-3-(хетероарил)-имидазо[1,2-а]пиримидини, лекарствени средства, които ги съдържат, използването им и метод за тяхното получаване | |
IL125076A (en) | Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them | |
EP1542978B1 (fr) | Nouvelles molecules bioactives | |
EP2119708B1 (fr) | Composés de tétrahydroquinazoline et leur utilisation dans la préparation de médicaments destinés au traitement et à la prévention de viroses | |
WO2010057418A1 (fr) | Dérivé de phénoxypyrimidine, sa méthode de synthèse et ses applications | |
JP2002544272A (ja) | 置換3−ピリジル−4−アリールピロール並びに関連した治療及び予防法 | |
CN115703761A (zh) | 作为wwp1抑制剂的化合物及其应用 | |
WO1992006087A1 (fr) | Derive d'ethynylphenyle a substitution pyridazinone et medicament contre les affections des organes circulatoires contenant ce derive en tant qu'ingredient actif | |
JP3455230B2 (ja) | インターロイキン―およびtnfアンタゴニストとして有用なピリジルピロール化合物 | |
CA1173831A (fr) | Methode d'obtention de nouveaux composes polyazaheterocycliques | |
CA2161436A1 (fr) | Naphtyridines antiproliferatives | |
JPH02169573A (ja) | 4‐ニトロフエニル‐ジヒドロピリジンアミド | |
MXPA00010153A (en) | Dihydropyrimidines | |
JPS60255778A (ja) | 2位置換ジヒドロピリミジン誘導体およびその製造法 | |
Pumphrey | Transition Metal-Catalyzed Intramolecular CH Amination Reactions and Applications in Drug Discovery | |
KR19990085815A (ko) | 캐테콜 히드라존 유도체, 이의 제조방법 및 그를함유한약제학적 조성물 |